A Phase 3 interventional study of paracetamol + caffeine and paracetamol in Common Cold, sponsored by GlaxoSmithKline. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-08.
Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Common Cold with a site in United Kingdom — none open to participants now, 1 under way, none of them phase 3. Common Cold · United Kingdom.
Among the 20 studies in Common Cold with a site in United Kingdom, this one is the 5th largest by enrollment, is one of 3 that started in 2011, is one of 4 in phase 3, and was the 9th registered.
219 studies on the registry are indexed under Common Cold; 23 are open to participants now.
Browse Common Cold studies →None of the 20 studies in Common Cold with a site in United Kingdom is open now. The open studies under Common Cold, anywhere →
Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger; 4 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 3 started in 2011.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 240 is above the median of 150 across 184 interventional studies indexed under Common Cold.
Median enrollment 89 across the 20 interventional studies. Of the 17 that completed or were terminated, 7 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 20 have an industry lead sponsor. The 10 most frequent:
GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 117 are open to participants now.
Of its 265 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.
GlaxoSmithKline has 9 studies filed under Common Cold — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Common Cold with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
highest dose of Paracetamol and caffeine
Drug: paracetamol + caffeine
lowest dose of Paracetamol and caffeine
Drug: paracetamol + caffeine
highest dose paracetamol
Drug: paracetamol
lowest dose paracetamol
Drug: paracetamol
Drug pages: Acetaminophen · Caffeine
paracetamol with caffeine
paracetamol
Change From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test
The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.
Time frame: Baseline to 60 minutes post treatment administration
Change From Baseline in Number of Accurate Responses to RVIP Cognitive Test
The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.
Time frame: Baseline to 120 minutes post treatment administration
Change From Baseline in Mean Time of Accurate Responses to RVIP Cognitive Task
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
Time frame: Baseline, 60 minutes and upto 120 minutes post treatment administration
Change From Baseline in Number of Inaccurate and Missed Responses to RVIP Cognitive Task
The no. of inaccurate responses to RVIP was determined from cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of screen. They responded to consecutive sequences of 3 odd or even numbers by pressing the corresponding response button. This was identified in the output file by a value of '1' in the 'TARGET=1' column. If a subject responded incorrectly to stimuli (pressed the response button at the wrong time), this was identified by a value of '-1' in the 'CORRECT=1' column. The no. of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button within 600 msecs of being presented with a string of 3 consecutive even or odd numbers), this was considered a missed response and was calculated as the no. of records where there was a value of '1' in the 'TARGET=1' column and a value of '0' in the 'CORRECT=1' column.
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Change From Baseline in Number of Accurate Responses to Sustained Attention Tasks (SAT) Cognitive Test
Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained auditory attention task, participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones. This was identified in the output file by a value of '8' in the 'NUMBER' column. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appeared in a continuous stream of letters presented on a screen. This was identified in the output file by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Change From Baseline in Mean Time of Accurate Responses to SAT Cognitive Task
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
Time frame: Baseline, 30 minutes and up to 60 minutes post treatment administration
Change From Baseline in Number of Incorrect and Missed Responses to SAT Cognitive Test
For sustained auditory attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones. It was identified in output file by a value of '8' in 'NUMBER' column. For sustained visual attention task, participants responded to letter 's' every time it appeared in a continuous stream of letters presented on screen. This was identified in output file by a value of 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), it was identified by a value of '-1' in 'CORRECT=1' column. The no. of incorrect responses was calculated as total no. of records where 'CORRECT=1' had a value of '-1'. The no. of missed responses (when subject failed to press the response button on hearing the number '8' or seeing the letter 's'), was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in the 'LETTER' column and a value of '0' in the 'CORRECT=1' column.
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Change From Baseline in Number of Valid Responses to Divided Attention Task (DAT) Cognitive Test
Auditory and visual attention of participants was evaluated using a validated Divided Attention task. Participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones or saw a letter 's' on the screen . This was identified in the output file by a value of '8' in the 'NUMBER' column or by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Change From Baseline in Mean Time of Accurate Responses to DAT Cognitive Test
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Change From Baseline in Number of Incorrect and Missed Responses to DAT Cognitive Test
For the Divided Attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones or seeing a letter 's' on screen. This was identified in the output file by a value of '8' in 'NUMBER' column or 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), this was identified by a value of '-1' in 'CORRECT=1' column. The number of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button on hearing the no. '8' or seeing the letter 's'), this was considered a missed response. The number of missed responses was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in 'LETTER' column and a value of '0' in the 'CORRECT=1' column.
Time frame: Baseline, 60 minutes and up to 120 minutes post treatment administration
Participants were recruited at the clinical site.
| Milestone | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Started | 45 | 45 | 75 | 75 |
| Intent to treat population | 45 | 45 | 75 | 75 |
| Safety population | 46 | 45 | 74 | 75 |
| Completed | 45 | 45 | 75 | 75 |
| Not completed | 0 | 0 | 0 | 0 |
The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.
| Correct responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Change From Baseline in Number of Accurate Responses to Rapid Visual Information Processing (RVIP) Cognitive Test | 8.3 ± 1.12 | 4.8 ± 1.12 | 4.5 ± 0.89 | 2.7 ± 0.88 |
The RVIP assessed the performance of visual attention mechanisms in remaining vigilant to periodically occurring events. The number of accurate responses to RVIP task was determined from the cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of the screen. During the RVIP task, participants responded to consecutive sequences of three odd or three even numbers by pressing the corresponding response button as quickly and accurately as possible. This was identified in the output file by a value of '1' in 'TARGET=1' column. Also, the response time (in seconds) was recorded in the 'RT' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'. The test lasted approximately 9 minutes and number of accurate responses to stimulus was calculated.
| Correct responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Change From Baseline in Number of Accurate Responses to RVIP Cognitive Test | 7.3 ± 1.16 | 4.4 ± 1.15 | 6.2 ± 0.91 | 3.5 ± 0.92 |
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
| milliseconds (msec) | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| 60 minutes | -1.4 (-92 to 102) | 2.4 (-113 to 313) | -0.9 (-134 to 119) | -9.9 (-108 to 142) |
| 120 minutes | -10.3 (-62 to 125) | -6.0 (-86 to 71) | -12.5 (-91 to 109) | -14.0 (-144 to 136) |
The no. of inaccurate responses to RVIP was determined from cognitive function computerised output. Participants monitored a series of single numbers (0-9) appearing in the centre of screen. They responded to consecutive sequences of 3 odd or even numbers by pressing the corresponding response button. This was identified in the output file by a value of '1' in the 'TARGET=1' column. If a subject responded incorrectly to stimuli (pressed the response button at the wrong time), this was identified by a value of '-1' in the 'CORRECT=1' column. The no. of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button within 600 msecs of being presented with a string of 3 consecutive even or odd numbers), this was considered a missed response and was calculated as the no. of records where there was a value of '1' in the 'TARGET=1' column and a value of '0' in the 'CORRECT=1' column.
| inaccurate and missed responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Incorrect responses at 60 minutes | -5.7 ± 3.43 | -2.8 ± 1.38 | 1.4 ± 1.96 | -2.4 ± 1.82 |
| Incorrect responses at 120 minutes | -4.5 ± 4.12 | -1.7 ± 1.78 | -0.8 ± 1.97 | -3.3 ± 1.56 |
| Missed responses at 60 minutes | -8.1 ± 1.03 | -4.8 ± 1.18 | -4.8 ± 0.83 | -3.1 ± 0.89 |
| Missed responses at 120 minutes | -7.6 ± 1.14 | -4.8 ± 1.15 | -6.5 ± 0.80 | -3.5 ± 0.92 |
Auditory and visual attention of participants was evaluated using a validated Sustained Attention task. For the sustained auditory attention task, participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones. This was identified in the output file by a value of '8' in the 'NUMBER' column. For the sustained visual attention task, participants were required to respond to the letter 's' every time it appeared in a continuous stream of letters presented on a screen. This was identified in the output file by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.
| Correct responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Number of Accurate Responses to SAT at 60 mins | 1.0 (-4 to 16) | 0.5 (-16 to 43) | 2.0 (-9 to 33) | 0.0 (-28 to 15) |
| Number of Accurate Responses to SAT at 120 mins | 2.0 (-17 to 28) | 1.0 (-11 to 42) | 1.0 (-6 to 30) | 2.0 (-10 to 26) |
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
| msec | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| 60 minutes | -16.7 ± 3.17 | -9.8 ± 3.17 | -10.8 ± 2.51 | -12.0 ± 2.47 |
| 120 minutes | -21.2 ± 3.48 | -10.4 ± 3.48 | -18.0 ± 2.74 | -15.4 ± 2.72 |
For sustained auditory attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones. It was identified in output file by a value of '8' in 'NUMBER' column. For sustained visual attention task, participants responded to letter 's' every time it appeared in a continuous stream of letters presented on screen. This was identified in output file by a value of 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), it was identified by a value of '-1' in 'CORRECT=1' column. The no. of incorrect responses was calculated as total no. of records where 'CORRECT=1' had a value of '-1'. The no. of missed responses (when subject failed to press the response button on hearing the number '8' or seeing the letter 's'), was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in the 'LETTER' column and a value of '0' in the 'CORRECT=1' column.
| incorrect and missed responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Incorrect responses at 60 minutes | -4.6 ± 1.00 | -1.1 ± 0.87 | -4.2 ± 0.74 | -1.6 ± 0.71 |
| Incorrect responses at 120 minutes | -4.4 ± 1.04 | -2.3 ± 0.98 | -4.3 ± 0.88 | -2.8 ± 0.82 |
| Missed responses at 60 minutes | -2.7 ± 0.74 | -1.9 ± 1.25 | -2.3 ± 0.70 | -0.8 ± 0.66 |
| Missed responses at 120 minutes | -2.8 ± 1.11 | -2.0 ± 1.19 | -2.2 ± 0.64 | -2.4 ± 0.63 |
Auditory and visual attention of participants was evaluated using a validated Divided Attention task. Participants were required to respond whenever they heard the number '8' in a continuous stream of numbers presented through headphones or saw a letter 's' on the screen . This was identified in the output file by a value of '8' in the 'NUMBER' column or by a value of 's' in the 'LETTER' column. If the subject correctly responded to the target, this was identified by a value of '1' in the 'CORRECT=1' column. The number of accurate responses was calculated as the total number of records where 'CORRECT=1' had a value of '1'.
| Correct responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| 60 minutes | 10.0 (-9 to 34) | 6.0 (-35 to 66) | 8.0 (-9 to 45) | 5.5 (-27 to 82) |
| 120 minutes | 11.0 (-6 to 53) | 6.0 (-15 to 88) | 9.0 (-23 to 59) | 7.0 (-23 to 86) |
The mean time of accurate responses was defined as the mean reaction time for the correct responses. For records with '1' in the 'CORRECT=1' column, the mean time of accurate response was calculated as the summation of the response time values divided by number of records with '1' in the 'CORRECT=1' column. The result was multiplied by 1000 to convert into milliseconds (msecs).
| msec | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| 60 minutes | -3.0 ± 2.94 | 1.5 ± 2.94 | -4.4 ± 2.33 | -2.2 ± 2.28 |
| 120 minutes | -11.0 ± 3.00 | -5.3 ± 3.00 | -8.0 ± 2.37 | -4.6 ± 2.34 |
For the Divided Attention task, participants were required to respond on hearing the no. '8' in a continuous stream of numbers through headphones or seeing a letter 's' on screen. This was identified in the output file by a value of '8' in 'NUMBER' column or 's' in 'LETTER' column. If a subject responded incorrectly (pressed the response button at the wrong time), this was identified by a value of '-1' in 'CORRECT=1' column. The number of incorrect responses was calculated as the total no. of records where 'CORRECT=1' had a value of '-1'. If the subject missed a target (failed to press the response button on hearing the no. '8' or seeing the letter 's'), this was considered a missed response. The number of missed responses was calculated as the no. of records where there was a value of '8' in 'NUMBER' column or 's' in 'LETTER' column and a value of '0' in the 'CORRECT=1' column.
| incorrect and missed responses | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) |
|---|---|---|---|---|
| Incorrect responses at 60 minutes | -6.5 ± 1.02 | -4.2 ± 1.11 | -5.4 ± 0.87 | -3.3 ± 0.81 |
| Incorrect responses at 120 minutes | -7.1 ± 1.01 | -4.9 ± 1.10 | -5.6 ± 0.86 | -5.0 ± 0.98 |
| Missed responses at 60 minutes | -10.2 ± 1.27 | -7.6 ± 2.08 | -9.8 ± 1.19 | -6.2 ± 1.50 |
| Missed responses at 120 minutes | -12.2 ± 1.54 | -9.1 ± 2.27 | -10.2 ± 1.43 | -7.8 ± 1.58 |
Collected over Adverse events were collected from the start of the treatment, and until 5 days following administration of the last dose of investigational product.. Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Paracetamol + Caffeine Combination (1000/130) | — | 0/46 (0%) | 0/46 (0%) |
| Paracetamol (1000) | — | 0/45 (0%) | 0/45 (0%) |
| Paracetamol + Caffeine Combination (500/65) | — | 0/74 (0%) | 0/74 (0%) |
| Paracetamol (500) | — | 0/75 (0%) | 0/75 (0%) |
| Age, Continuous(Years) | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) | Total |
|---|---|---|---|---|---|
| Mean | 20.0 ± 1.56 | 20.0 ± 1.74 | 20.6 ± 4.19 | 20.2 ± 2.80 | 20.2 ± 2.98 |
| Sex: Female, Male(Participants) | Paracetamol + Caffeine Combination (1000/130) | Paracetamol (1000) | Paracetamol + Caffeine Combination (500/65) | Paracetamol (500) | Total |
|---|---|---|---|---|---|
| Female | 31 | 28 | 47 | 48 | 154 |
| Male | 15 | 17 | 27 | 27 | 86 |
The record gives a start of Nov 2011, a primary completion of Nov 2012 and a completion of Nov 2012. It does not say whether these dates are actual or estimated.
Results were first posted in Jul 2014, 1 year 8 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Acetaminophen · Caffeine